Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-5204 in Acute or Chronic Gastritis
NCT02282670Phase 3Unknown
- Sponsor
- Dong-A ST
- Start
- Apr 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Stillen in acute gastritis and chronic gastritis, sponsored by Dong-A ST. Primary endpoint: Improvement of stomach erosions by endoscopy at 2 weeks. Status: unknown.
02
Drugs
Stillen
03
Conditions
acute gastritischronic gastritis
Beyond the preview
Go deeper on NCT02282670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02282670.